ES2160647T3 - Preparacion percutanea de tulobuterol. - Google Patents

Preparacion percutanea de tulobuterol.

Info

Publication number
ES2160647T3
ES2160647T3 ES95105507T ES95105507T ES2160647T3 ES 2160647 T3 ES2160647 T3 ES 2160647T3 ES 95105507 T ES95105507 T ES 95105507T ES 95105507 T ES95105507 T ES 95105507T ES 2160647 T3 ES2160647 T3 ES 2160647T3
Authority
ES
Spain
Prior art keywords
tulobuterol
percutaneous preparation
sensitive adhesive
pressure
dissolved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95105507T
Other languages
English (en)
Inventor
Keiji Yamamoto
Yoshihisa Nakano
Saburo Otsuka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Abbott Japan Co Ltd
Original Assignee
Hokuriku Pharmaceutical Co Ltd
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical Co Ltd, Nitto Denko Corp filed Critical Hokuriku Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2160647T3 publication Critical patent/ES2160647T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNA PREPARACION DE ABSORCION PERCUTANEA CONTIENE UN SOPORTE Y, ESTA FORMADA EN UNO DE SUS LADOS POR UNA CAPA DE YESO QUE CONTIENE UN ADHESIVO SENSIBLE A LA PRESION Y TULOBUTEROL EN UNA CANTIDAD NO INFERIOR A SU SATURACION DE SOLUBILIDAD EN EL ADHESIVO SENSIBLE A LA PRESION. EL TULOBUTEROL CONTENIDO EN LA CAPA DE YESO COMPUESTA DE TULOBUTEROL DISUELTO Y TULOBUTEROL CRISTALINO CON EL INDICE DEL CONTENIDO DEL TULOBUTEROL CRISTALINO DE MANER QUE EL TULOBUTEROL DISUELTO SEA DE 0.1 A 10.
ES95105507T 1994-04-14 1995-04-12 Preparacion percutanea de tulobuterol. Expired - Lifetime ES2160647T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6075600A JP2753800B2 (ja) 1994-04-14 1994-04-14 経皮吸収型製剤

Publications (1)

Publication Number Publication Date
ES2160647T3 true ES2160647T3 (es) 2001-11-16

Family

ID=13580865

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95105507T Expired - Lifetime ES2160647T3 (es) 1994-04-14 1995-04-12 Preparacion percutanea de tulobuterol.

Country Status (7)

Country Link
US (1) US5639472A (es)
EP (1) EP0677290B1 (es)
JP (1) JP2753800B2 (es)
AT (1) ATE203158T1 (es)
CA (1) CA2146723C (es)
DE (1) DE69521734T2 (es)
ES (1) ES2160647T3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0000403A3 (en) * 1995-10-17 2000-10-30 Nitto Denko Corp Percutaneous tulobuterol preparation and process for producing the same
JP4792406B2 (ja) * 1997-12-12 2011-10-12 日東電工株式会社 経皮吸収型製剤
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
GB0110284D0 (en) * 2001-04-26 2001-06-20 Avery Dennison Corp Mouldable hydrocolloid adhesive compositions
KR100439659B1 (ko) * 2001-06-23 2004-07-12 제일약품주식회사 툴로부테롤을 함유하는 경피흡수용 패취제
KR100535302B1 (ko) * 2002-02-01 2005-12-08 주식회사 태평양 툴로부테롤 함유 경피흡수형 제제
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
JP2004224701A (ja) * 2003-01-17 2004-08-12 Yuutoku Yakuhin Kogyo Kk 外用貼付剤
US7456236B2 (en) 2003-03-27 2008-11-25 Cosmed Pharmaceutical Co., Ltd. Adhesive for percutaneous absorption, adhesive composition for percutaneous absorption and preparation for percutaneous absorption
JP5512910B2 (ja) * 2003-04-10 2014-06-04 テイカ製薬株式会社 ツロブテロール含有経皮吸収製剤およびこれを使用する貼付剤
JP4617069B2 (ja) * 2003-06-16 2011-01-19 コスメディ製薬株式会社 貼付剤
US8029820B2 (en) * 2003-06-20 2011-10-04 Teikoku Seiyaku Co., Ltd. Patches containing tulobuterol
US20070077285A1 (en) * 2003-11-21 2007-04-05 Hiroko Udagawa Adhesive skin patch
CN1297257C (zh) * 2004-01-02 2007-01-31 上海现代药物制剂工程研究中心有限公司 含有妥洛特罗的压敏胶，透皮贴剂及制备方法和应用
JP4857430B2 (ja) * 2004-10-13 2012-01-18 財団法人ヒューマンサイエンス振興財団 貼付剤型強心薬
JP5243254B2 (ja) * 2006-10-11 2013-07-24 久光製薬株式会社 結晶含有貼付剤
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
US8801678B2 (en) 2012-01-20 2014-08-12 Carefusion 303, Inc. Piston for a needleless valve system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
EP0189861A3 (en) * 1985-01-26 1988-02-17 Showa Denko Kabushiki Kaisha Percutaneous absorption accelerator for ionic water-soluble medicine
JPS6310716A (ja) * 1986-07-02 1988-01-18 Teijin Ltd β−刺激薬外用剤
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
IT1251469B (it) * 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
ES2180546T3 (es) * 1992-07-23 2003-02-16 Hisamitsu Pharmaceutical Co Composicion basica administrable percutaneamente y composicion de farmaco preparada a partir de ella.

Also Published As

Publication number Publication date
EP0677290B1 (en) 2001-07-18
EP0677290A1 (en) 1995-10-18
DE69521734T2 (de) 2001-11-08
CA2146723A1 (en) 1995-10-15
CA2146723C (en) 2003-12-30
JPH07285854A (ja) 1995-10-31
ATE203158T1 (de) 2001-08-15
JP2753800B2 (ja) 1998-05-20
DE69521734D1 (de) 2001-08-23
US5639472A (en) 1997-06-17

Similar Documents

Publication Publication Date Title
ES2160647T3 (es) Preparacion percutanea de tulobuterol.
ATE108329T1 (de) Morphin enthaltende zusammensetzung.
TW325406B (en) Percutaneous absorption preparation
FI903213A0 (fi) Foer transdermal administration avsett gestoden innehaollande medel.
DE68912237D1 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
DE68907464T2 (de) Sauerstoffabsorptionsblatt.
DE69203695T2 (de) Sauerstoff aufnehmende Zusammensetzung.
DE3780700T2 (de) Klebstoff fuer perkutane verabreichung.
FI98342B (fi) Pitkävaikutteinen viskoosinen liimautuva ehkäisykoostumus
DE69301390D1 (de) Klebmittelzusammensetzung mit funktionalen Füllstoff
DE3483104D1 (de) In form eines haftenden streifens vorliegendes arzneimittelpraeparat fuer perkutane absorption.
DE68900179D1 (de) Daempfungsvorrichtung fuer turmartige strukturen.
DE69508342D1 (de) Zusammensetzung zur perkutan Absorption
DK0503379T3 (da) Testindretning med prøvetilførselsorganer
DE68910947T2 (de) Perkutane-Herstellung von Tulobuterol.
DE3881861T2 (de) Bahnspannungsvorrichtung.
NO900027D0 (no) Dobbeltdiffusoer med tilbakespylingsstempler.
DE68909636T2 (de) Adhäsive Zusammensetzung.
NO891824D0 (no) Klebemiddelblandinger.
DE3668929D1 (de) Einrichtung zur planierschildbefestigung und -stabilisierung.
DE58906436D1 (de) Konzentrierte und flüssige wasserhaltige Tensidzusammensetzung und deren Verwendung.
AU7717587A (en) Nicorandil percutaneous absorption composition
DE68910160D1 (de) Klebstoff-Zusammensetzung.
FI892622A (fi) Sjaelvlimmande saekerhetsdataunderlag och dess anvaendning foer att goera handlingar foerfalskningsodugliga.
ATE270418T1 (de) Emaillierter einschub

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 677290

Country of ref document: ES